296 related articles for article (PubMed ID: 34771575)
41. Vessel pruning or healing: endothelial metabolism as a novel target?
Cantelmo AR; Pircher A; Kalucka J; Carmeliet P
Expert Opin Ther Targets; 2017 Mar; 21(3):239-247. PubMed ID: 28081641
[TBL] [Abstract][Full Text] [Related]
42. Krüppel-like factor 6 mediates pulmonary angiogenesis in rat experimental hepatopulmonary syndrome and is aggravated by bone morphogenetic protein 9.
Yang Y; Yu H; Yang C; Zhang Y; Ai X; Wang X; Lu K; Yi B
Biol Open; 2019 Jun; 8(6):. PubMed ID: 31189661
[TBL] [Abstract][Full Text] [Related]
43. New insights into BMP9 signaling in organ fibrosis.
Tang N; Rao S; Ying Y; Huang Y
Eur J Pharmacol; 2020 Sep; 882():173291. PubMed ID: 32574673
[TBL] [Abstract][Full Text] [Related]
44. Regulation of bone morphogenetic protein-4 by matrix GLA protein in vascular endothelial cells involves activin-like kinase receptor 1.
Yao Y; Zebboudj AF; Shao E; Perez M; Boström K
J Biol Chem; 2006 Nov; 281(45):33921-30. PubMed ID: 16950789
[TBL] [Abstract][Full Text] [Related]
45. Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations.
Ricard N; Bidart M; Mallet C; Lesca G; Giraud S; Prudent R; Feige JJ; Bailly S
Blood; 2010 Sep; 116(9):1604-12. PubMed ID: 20501893
[TBL] [Abstract][Full Text] [Related]
46. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
[TBL] [Abstract][Full Text] [Related]
47. Rethinking growth factors: the case of BMP9 during vessel maturation.
Medina-Jover F; Riera-Mestre A; Viñals F
Vasc Biol; 2022 Feb; 4(1):R1-R14. PubMed ID: 35350597
[TBL] [Abstract][Full Text] [Related]
48. Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain.
Chen W; Guo Y; Walker EJ; Shen F; Jun K; Oh SP; Degos V; Lawton MT; Tihan T; Davalos D; Akassoglou K; Nelson J; Pile-Spellman J; Su H; Young WL
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):305-10. PubMed ID: 23241407
[TBL] [Abstract][Full Text] [Related]
49. The Expression of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) in Hippocampal Arterioles Declines During Progression of Alzheimer's Disease.
Anderson KE; Bellio TA; Aniskovich E; Adams SL; Blusztajn JK; Delalle I
Cereb Cortex Commun; 2020; 1(1):tgaa031. PubMed ID: 32974611
[TBL] [Abstract][Full Text] [Related]
50. Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development.
Chen H; Brady Ridgway J; Sai T; Lai J; Warming S; Chen H; Roose-Girma M; Zhang G; Shou W; Yan M
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11887-92. PubMed ID: 23812757
[TBL] [Abstract][Full Text] [Related]
51. Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.
Shao ES; Lin L; Yao Y; Boström KI
Blood; 2009 Sep; 114(10):2197-206. PubMed ID: 19506300
[TBL] [Abstract][Full Text] [Related]
52. Immunotherapeutic Targeting of Tumor-Associated Blood Vessels.
Fabian KL; Storkus WJ
Adv Exp Med Biol; 2017; 1036():191-211. PubMed ID: 29275473
[TBL] [Abstract][Full Text] [Related]
53. Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic Fibrosis.
Desroches-Castan A; Tillet E; Ricard N; Ouarné M; Mallet C; Belmudes L; Couté Y; Boillot O; Scoazec JY; Bailly S; Feige JJ
Hepatology; 2019 Oct; 70(4):1392-1408. PubMed ID: 30964206
[TBL] [Abstract][Full Text] [Related]
54. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
Viallard C; Larrivée B
Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
[TBL] [Abstract][Full Text] [Related]
55. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
56. Targeting tumor vascularization: promising strategies for vascular normalization.
Zheng R; Li F; Li F; Gong A
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2489-2505. PubMed ID: 34148156
[TBL] [Abstract][Full Text] [Related]
57. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling.
Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y
J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928
[TBL] [Abstract][Full Text] [Related]
58. DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1.
Rostama B; Turner JE; Seavey GT; Norton CR; Gridley T; Vary CP; Liaw L
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2626-37. PubMed ID: 26471266
[TBL] [Abstract][Full Text] [Related]
59. BMP9 exhibits dual and coupled roles in inducing osteogenic and angiogenic differentiation of mesenchymal stem cells.
Xiao H; Wang X; Wang C; Dai G; Zhu Z; Gao S; He B; Liao J; Huang W
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32478395
[TBL] [Abstract][Full Text] [Related]
60. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.
Larrivée B; Prahst C; Gordon E; del Toro R; Mathivet T; Duarte A; Simons M; Eichmann A
Dev Cell; 2012 Mar; 22(3):489-500. PubMed ID: 22421041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
